Preprint · OA
via OpenAlex
TREATMENT OF TYPE 2 DIABETES
Acta Clinica Belgica · 2003 · ▲ 42 citations
Abstract
Type 2 diabetes is a heterogeneous disease resulting from a dynamic interaction between defects in insulin secretion and insulin action. As most subjects are overweighted or obese, the initial treatment is optimization of the meal plan and enhancement of physical activity in order to obtain sustained weight reduction. In case of failure of life-style changes, various oral antihyperglycaemic agents may be used. Some are targeting defective insulin secretion (sulphonylureas, glinides) while others are targeting insulin resistance (metformin, thiazolidinediones). Criteria of drug selection should include both patient's characteristics (body weight, age, degree of hyperglycaemia, comorbidities) and pharmacological properties of the compound (mode of action, safety profile, cost). Monotherapy is usually recommended first, but combined therapy using drugs with additive or synergistic effects may be required to obtain appropriate blood glucose control. As the natural history of the disease is characterized by a progressive exhaustion of beta cells, exogenous insulin may be required in the long term, usually in combination with oral agents. Finally, as patients with type 2 diabetes are insulin-resistant and often have a metabolic syndrome, a multifactorial intervention including aggressive treatment of arterial hypertension and dyslipidaemia is recommended in order to reduce the incidence of cardiovascular complications.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1179/acb.2003.58.5.010
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Scheen, A.J. (2003). TREATMENT OF TYPE 2 DIABETES. <em>Acta Clinica Belgica</em>. https://doi.org/10.1179/acb.2003.58.5.010
Vancouver
Scheen AJ. TREATMENT OF TYPE 2 DIABETES. Acta Clinica Belgica. 2003. doi:10.1179/acb.2003.58.5.010.
BibTeX
@unpublished{andr2003TREATM,
title = {TREATMENT OF TYPE 2 DIABETES},
author = {André Jacques Scheen},
journal = {Acta Clinica Belgica},
year = {2003},
doi = {10.1179/acb.2003.58.5.010},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JAMA 2025
Preprint · OA
Diagnosis and Treatment of Type 2 Diabetes in Adults
Diabetologia 2005
Open access · OA
Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
Diabetes Care 2007
Open access · OA
Exercise Capacity and Cardiovascular/Metabolic Characteristics of Overweight and Obese Individuals With Type 2 Diabetes
International Journal of Obesity 2006
Citation only
Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes
Diabetologia 2008
Open access · OA
Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease
Medicine & Science in Sports & Exercise 2000
Citation only